Aeron C Hurt Selected Research

Zanamivir (Relenza)

11/2020	Viral burden, inflammatory milieu and CD8+ T-cell responses to influenza virus in a second-generation thiazolide (RM-5061) and oseltamivir combination therapy study.
8/2019	A novel I117T substitution in neuraminidase of highly pathogenic avian influenza H5N1 virus conferring reduced susceptibility to oseltamivir and zanamivir.
1/2019	Circulation and characterization of seasonal influenza viruses in Cambodia, 2012-2015.
1/2018	Selection of multi-drug resistant influenza A and B viruses under zanamivir pressure and their replication fitness in ferrets.
1/2016	Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2014-2015.
8/2015	Evaluation of a dry powder delivery system for laninamivir in a ferret model of influenza infection.
5/2015	Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2013-2014.
1/2015	Zanamivir-resistant influenza viruses with Q136K or Q136R neuraminidase residue mutations can arise during MDCK cell culture creating challenges for antiviral susceptibility monitoring.
10/2014	Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2012-2013.
11/2013	Review of the clinical effectiveness of the neuraminidase inhibitors against influenza B viruses.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Aeron C Hurt Research Topics

Disease

97	Human Influenza (Influenza) 11/2022 - 01/2003
39	Infections 11/2020 - 01/2005
5	Influenza in Birds (Avian Flu) 11/2019 - 04/2008
3	Virus Diseases (Viral Diseases) 11/2020 - 12/2018
2	COVID-19 01/2021 - 01/2021
2	Herpesviridae Infections (Herpesvirus Infection) 01/2018 - 08/2015
1	Hypertension (High Blood Pressure) 01/2022
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2022
1	Weight Loss (Weight Reduction) 01/2019
1	Inflammation (Inflammations) 01/2015
1	Body Weight (Weight, Body) 01/2015
1	Coinfection 09/2010
1	Viral Pneumonia 02/2010
1	Respiratory Insufficiency (Respiratory Failure) 02/2010

Drug/Important Bio-Agent (IBA)

46	Neuraminidase (Sialidase)IBA 01/2021 - 01/2003
45	Antiviral Agents (Antivirals)IBA 11/2022 - 01/2005
38	Oseltamivir (Tamiflu)FDA Link 11/2020 - 01/2003
18	Zanamivir (Relenza)FDA Link 11/2020 - 01/2003
15	Pharmaceutical PreparationsIBA 11/2022 - 12/2007
8	VaccinesIBA 01/2022 - 09/2008
8	baloxavirIBA 01/2021 - 01/2018
8	Hemagglutinins (Hemagglutinin)IBA 01/2019 - 04/2008
7	Influenza Vaccines (Influenza Vaccine)FDA Link 01/2022 - 01/2006
6	Amino Acids FDA Link 01/2019 - 01/2009
6	laninamivirIBA 01/2016 - 11/2013
6	peramivirIBA 01/2016 - 04/2008
4	EndonucleasesIBA 01/2020 - 01/2018
4	Proteins (Proteins, Gene)FDA Link 01/2020 - 01/2015
4	AntibodiesIBA 10/2019 - 11/2013
4	oseltamivir carboxylateIBA 09/2004 - 01/2003
3	nitazoxanide (NTZ)FDA Link 01/2020 - 11/2017
3	AntigensIBA 10/2019 - 06/2007
3	EpitopesIBA 01/2019 - 11/2013
3	Monoclonal AntibodiesIBA 01/2019 - 11/2013
2	Neutralizing AntibodiesIBA 01/2021 - 01/2019
2	NucleoproteinsIBA 01/2020 - 10/2019
2	AdamantaneIBA 02/2013 - 01/2012
2	EnzymesIBA 09/2004 - 07/2004
1	CytokinesIBA 11/2021
1	bamlanivimabIBA 01/2021
1	bamlanivimab and etesevimab drug combinationIBA 01/2021
1	casirivimab and imdevimab drug combinationIBA 01/2021
1	Oxygen (Dioxygen)IBA 01/2021
1	aminoxanideIBA 11/2020
1	Codon (Codons)IBA 01/2020
1	Membrane Proteins (Integral Membrane Proteins)IBA 01/2019
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2019
1	Viral HemagglutininsIBA 01/2019
1	DNA VaccinesIBA 01/2018
1	tizoxanideIBA 11/2017
1	Fc Receptors (Fc Receptor)IBA 07/2017
1	feralIBA 01/2016
1	RNA (Ribonucleic Acid)IBA 01/2016
1	PowdersIBA 08/2015
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 01/2011
1	Histidine (L-Histidine)FDA Link 10/2010
1	Tyrosine (L-Tyrosine)FDA Link 10/2010
1	Amantadine (Aman)FDA LinkGeneric 01/2009
1	Rimantadine FDA LinkGeneric 01/2009
1	Anti-Bacterial Agents (Antibiotics)IBA 06/2007

Therapy/Procedure

11	Therapeutics 01/2021 - 01/2005
2	Chemoprevention 01/2015 - 01/2012
1	Drug Therapy (Chemotherapy) 01/2019
1	Injections 04/2008
1	Length of Stay 06/2007